SMi Group’s 13th Annual Conference: RNA Therapeutics 2022 9th – 10th February 2022 London, UK www.therapeutics-rna.com/INICOP Sponsored by: BIA Separations & eTheRNA Immunotherapies Bolstering the latest advances and opportunities in RNA-based medicine The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development. The 2022 agenda will explore innovations in novel and targeted delivery, RNAi innovations and antisense oligonucleotide therapeutics. Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of RNA with case studies on the treatment of cardiovascular disease, neurological diseases, and oncology. Join us in February 2022, as SMi’s 13th annual RNA Therapeutics Conference brings together industry experts from leading RNA therapeutics companies to gain an expert and holistic view on the latest developments of the industry.